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Mammalian tyrosinase as currently defined has two catalytic functions: 1) the
oxidation of tyrosine to L-3,4-dihydroxyphenylalanine (dopa) and 2) the oxidation
of dopa to dopa quinone (1-9). Although an imposing body of evidence has been
advanced in support of this interpretation, Okun and associates have recently chal-
lenged the prevailing concept of the action of tyrosinase (10, 11). They have pro-
posed that within mammalian melanocytes, the oxidation of tyrosine to dopa is
mediated by peroxidase whereas the oxidation of dopa to dopa quinone is regulated
by dopa oxidase. In their view it is the coupling of peroxidase and dopa oxidase
which accounts for "tyrosinase" activity in mammals; i.e., a tyrosinase with cata-
lytic action directed toward both tyrosine and dopa does not exist.
Our previous studies have demonstrated that polyacrylamide gel electrophero-
grams of supernatant fractions from homogenates of mammalian pigmented hair
bulbs reveal the presence of multiple molecular forms of tyrosinase (12, 13). Ex-
tensive examination of hair bulbs from various coat-color mutants of the mouse
indicate that the multiple molecular forms of tyrosinase are under genetic control
(12, 13). Depending on genic constitution, a maximum of three electrophoretically
separable forms of tyrosinase (T1, T,-T3) are demonstrable.2 In keeping with gen-
eral practice (14, 15), dopa has been the melanogenic substrate used in our labora-
tory to demonstrate tyrosinase within polyacrylamide gels. Accordingly, there have
been two basic assumptions: first, that tyrosinase revealed by dopa also is able
'This investigation was supported by PHS Research Grant CA-06097 from the National
Cancer Institute.
2T2 and T3 initially are observed as two closely migrating discrete bands of activity but
rapidly merge as melanin is deposited in polyacrylamide gels incubated in melanogenic
substrates. Since only a single T2 band is observed in the soluble fraction of mouse melanoma
extracts (14, 15), it is possible that a distinction between T2 and T, may not be warranted;
hence, in referring to T2 and T, they are joined by a hyphen to reflect this unresolved
problem.
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to oxidize tyrosine; second, that peroxidase is not involved in the deposition of
dopa-melanin under the conditions established for demonstrating tyrosinase activity
within polyacrylamide gels.
This paper presents evidence that the multiple forms of tyrosinase from mouse
melanoma and hair bulbs possess the ability to utilize both tyrosine and dopa in
the initial steps of melanin synthesis. The evidence suggests that, although peroxi-
dase is present in hypodermal ("hair bulb") and melanoma extracts, it can be
distinguished from multiple forms of tyrosinase defined by their ability to oxidize
both tyrosine and dopa. Specifically, it will be shown that 1) all forms of tyro-
sinase(T1 andT2-T3) retain the ability to convert tyrosine and dopa to melanin
when catalase is present in quantities sufficient to block peroxidase activity within
polyacrylamide gel electropherograms, 2) peroxidase overlapsT2-T3 in its electro-
phoretic mobility but is clearly distinct from T, in polyacrylamide gels, and 3)T1,
selectively isolated from polyacrylamide gels, hydroxylates tyrosine in the presence
of catalase as demonstratedby the sensitive Pomerantz radioassay (9).
The enhancement of tyrosinase activity by trypsin treatment of hair bulb and
melanoma supernatant fractions observed during this study provides preliminary
evidence for the existence of a mammalian protyrosinase. The concept of a verte-
brate protyrosinase activated by an appropriate endopeptidase has received strong
support from research on amphibian epidermis by McGuire and associates (16,
17). In the present study the term "protyrosinase" is used guardedly since neither
its precise nature nor its position in the biosynthetic pathway leading to active
mammalian tyrosinase is known.
MATERIALS AND METHODS
The following strains of mice were used: C57BL/6J (a/a), Y/Wi (AY/A),
C3HB/St(mibw/mibw), BUB/Wi (a/a, c/c), C57BL/Ha-e (a/a, e/e). The genes
designated indicate departures from the agouti or "wild-type" genotype (13).
Hair bulbs, together with the adipose tissue in which they were embedded, were
collected 10 days postplucking (18). Each hair bulb preparation was homogenized
in a Potter-Elvehjem homogenizer in chilled sucrose (wet weight/volume = 0.3
g/ml). Homogenates of Harding-Passey melanoma maintained by serial transplan-
tation in C3HB mice were treated in a similar fashion with the exception that the
wet weight/volume was 0.1 g/ml. The homogenates were centrifuged at 35,000
g for 30 min at0°C. In a few cases, the 35,000 g supernatant fractions were recen-
trifuged at 100,000 g for1 hr at0°C. When TPCK-trypsin (Worthington 230
U/mg) was used, it was added to portions of the supernatant fractions (0.3 mg
trypsin/ml supernatant) 5-10 min prior to electrophoresis. Aliquots (0.2 ml) of
trypsin-treated and untreated supernatant fractions were subjected to polyacryl-
amide gel electrophoresis according to the method of Davis (19) as modified by
Burnett, Seiler, and Brown (14) and Holstein,Burnett, and Quevedo (12).
Demonstration of Tyrosinase within Polyacrylamide Gels
After electrophoresis, the gels were neutralized in 1.0 M phosphate buffer (pH
6.8) for 30 min. The multiple forms of tyrosinase were routinely visualized by
incubation of the gels for several hours in a solution of 0.1 M phosphate buffer
(pH 6.8) containing either 0.15% L-3,4-dihydroxyphenylalanine (dopa) or 0.2
mM L-tyrosine and 0.2 mM dopa. In one series of experiments involving C57BL
hair bulb supernatant fractions, dopa was maintained constant at 0.2 mM and tyro-
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sine varied from 0.2 to 8 mM, a variation in tyrosine/dopa concentration of 1:1
to 40:1. The ability of the multiple forms of tyrosinase to convert tyrosine and
dopa to melanin in the presence of catalase (Worthington 3100 U/mg) was dem-
onstrated by adding catalase to the gel incubation medium in a concentration of
0.1 mg/ml. The quantity of catalase added was sufficient to block the activity of
peroxidase. To preserve the tyrosinase patterns, all gels were stored in 7.5% acetic
acid.
The effect of trypsin on isolated tyrosinase was determined as follows: After
polyacrylamide gel electrophoresis and neutralization, one of 6-to-12 gels was
placed in dopa buffer while the others were maintained in 0.1 M phosphate buffer.
The Rx, values of the T1 and T2-T3 bands in the dopa-treated gel were determined.
Based on these Rx values, the approximate T1 and T2-T3 regions in the unstained
gels were cut out, diced, and placed in a beaker containing 3-5 ml of 0.25 M su-
crose. Elution of the tyrosinase from the diced gels was accomplished by continu-
ous stirring for 15-20 hr at 40C. Subsequently, the sucrose solution containing
eluted enzyme was separated from the diced gel by low-speed centrifugation. The
isolated T1 and T2-T,, tyrosinases from non-trypsin-treated supernatant fractions
from hair bulbs of C57BL mice were treated with trypsin, resubjected to electro-
phoresis, and tested for activity toward dopa.
Demonstration of Peroxidase within Polyacrylamide Gels
Peroxidase activity was determined by placing the electropherograms of hair
bulb and melanoma supernatant fractions in benzidine reagent following the proce-
dure reported by van Duijn (11, 20). No peroxidase activity was observed when
peroxide was omitted from the benzidine reagent. The addition of catalase to the
standard benzidine reagent in a concentration of 0.1 mg/ml completely inhibited
peroxidase activity within the electropherograms of hair bulb and melanoma super-
natant fractions.
Tyrosine Hydroxylating Capacity of Isolated T1
The ability of T1 isolated from trypsin-treated and untreated supernatant frac-
tions of Harding-Passey melanoma to hydroxylate tyrosine to dopa was measured
according to the method of Pomerantz (9) with certain modifications. The reaction
mixture contained 0.15 jumole L-tyrosine, 0.0025 mCi 3, 5-3H-L-tyrosine (ICN,
sp act 14 Ci/Mmole) and 0.15 Mumole dopa in each 1.25-ml volume of 0.1 M phos-
phate buffer (pH 6.9). To 10 ml of this reaction mixture 1 ml of 0.25 M sucrose
containing eluted T1 was added. The background included the counts from a con-
trol to which no enzyme had been added. The T1 was eluted from the polyacryl-
amide gels following the method described above. An additional method employed
to ensure precise localization of T1 was to incubate all gels in dopa reagent until
a light deposit of melanin was evident at the tyrosinase positions. The T1 region
was then cut out, diced, and the enzyme eluted for the radioassay.
RESULTS
Enhancement of Tyrosinase Activity by Trypsinization of Supernatant Fractions
Trypsin treatment of 35,000 g and 100,000 g supernatant fractions of hair bulb
extracLs from C57BL (black) mice resulted in a marked increase in melanin depo-
sition at the T1 position when the polyacrylamide gel electropherograms were incu-
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FIG. 1. Activity patterns of tyrosinase from follicular melanocytes of C57BL (black)
mice: (A) untreated 35,000 g supernatant fraction; (B) trypsin-treated 35,000 g supernatant
fraction; (C) untreated 100,000 g supernatant fraction; (D) trypsin-treated 100,000 g super-
natant fraction. (All gels incubated in 0.15% dopa.)
bated in 0.15% dopa (Fig. 1). No definite enhancement of activity was found
at the T2-T3 position. Also, based on visual inspection of the electropherograms,
there was no marked difference in the response of the 35,000 g and 100,000 g
supernatant fractions to trypsinization. When T1 and T2-T3 from untreated black
hair bulb extracts were isolated from polyacrylamide gels, treated with trypsin, and
resubjected to electrophoresis, no enhancement of dopa-melanin deposition was
found at either the T1 or T2-T3 positions (Fig. 2). In addition, trypsinization did
not appear to convert T1 into T,-T3 or vice versa.
The 35,000 g supernatant fractions of hair bulb extracts from lethal yellow
(AY/A) and recessive yellow (e/e) mice revealed enhanced deposition of dopa-
melanin at the T1 position when treated with trypsin prior to electrophoresis (Fig.
3). T2-T3 activity normally absent in hair bulbs of lethal yellow and recessive yel-
low mice was not "induced" by trypsinization of the supernatant fractions. Occa-
sionally, a slight darkening was noted at the T2-T3 position in gels incubated for
prolonged periods in dopa. This appeared to be associated with the presence of
hemoglobin which approximated T2-T3 in its electrophoretic mobility. Trypsiniza-
tion of supernatant fractions of hair bulb extracts from albino mice did not result
in the deposition of dopa-melanin within the electropherograms. Treatment of
35,000 g supernatant fractions from Harding-Passey melanoma extracts with tryp-
sin resulted in markedly enhanced dopa-melanin deposition at the T1, but not the
T2, position in electropherograms (Fig. 4).
Tyrosine Utilization by Tyrosinase from Trypsinized and Nontrypsinized
Supernatants
Tyrosine utilization by T1 and T2-T3 in melanin formation was demonstrated
in several ways. Increased melanin deposition was found in polyacrylamide gel elec-
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FIG. 2. Activity patterns of tyrosinase isolated from electropherograms of C57BL hair
bulb extracts and resubjected to electrophoresis: (A) T,; (B) T,, trypsin treated prior to
reelectrophoresis; (C) T2-T,; (D) T2-T,, trypsin treated prior to reelectrophoresis. (All gels
incubated in 0.15% dopa.)
tropherograms of nontrypsinized C57BL hair bulb extracts when tyrosine and dopa
were both present in the incubation medium at a concentration of 0.2 mM. The
melanin bands were significantly darker than in gels incubated in 0.2 mM dopa
alone (Fig. 5). Similar findings were obtained with extracts of Harding-Passey
melanoma (Fig. 6). In both cases tyrosine utilization was particularly evident at
the T1 position when the supernatant fractions were treated with trypsin prior to
electrophoresis; the elevated melanogenic activity presumably was the result of an
increased amount of tyrosinase at the T1 position. Examination of trypsinized hair
bulb supernatant fractions from C57'BL mice revealed that the molar ratio of
tyrosine to dopa was critical in demonstrating tyrosinase activity. When dopa was
maintained at 0.2 mM in the gel incubation medium and tyrosine presented in con-
centrations of 1: 1 and 2: 1 relative to dopa, melanin deposition was enhanced
compared to that in gels incubated in dopa alone. At tyrosine/dopa ratios from
10: 1 to 40: 1, melanogenesis was clearly inhibited within the electropherograms
(Fig. 7).
Peroxidase overlapped T2-T3 in electrophoretic mobility and was clearly distinct
from T1 (Figs. 4, 5, 8, 9). As revealed by the benzidine test, peroxidase from
hair bulb preparations usually took the form of two major bands of activity, but,
on occasion, additional minor bands were noted. Peroxidase from Harding-Passey
melanoma routinely exhibited several prominent bands. In both hair bulb and mela-
noma preparations tyrosine utilization by T1 clearly occurred in the absence of
comigratory peroxidase.
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FIG. 3. Activity patterns of tyrosinase from follicular melanocytes of yellow mice: (A)
untreated supernatant fraction from recessive yellow; (B) trypsin-treated supernatant fraction
from recessive yellow; (C) untreated supernatant fraction from lethal yellow; (D) trypsin-
treated supernatant fraction from lethal yellow. (All gels incubated in 0.15% dopa.)
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FIG. 4. Activity patterns of tyrosinase and peroxidase from Harding-Passey melanoma:
(A) tyrosinase in untreated supernatant (substrate r015%dopa), (B) tyrosinase in trypsin-
treated supernatant fraction (substrate = 0.15% dopa); (C) peroxidase in trypsin-treated
supernatant fraction (benzidine reagent).
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FIG. 5. Activity patterns of tyrosinase and peroxidase from hair bulb extracts of C57BL
mice. Electropherograms of untreated supernatant fractions incubated in (A) 0.2 mM dopa,
(B) 0.2 mM dopa and 0.2 mM L-tyrosine, and (C) benzidine reagent; electropherograms
of trypsin-treated supernatant fractions incubated in (D) 0.2 mM dopa and 0.2 mM L-tyrosine,
(E) 0.2 mM dopa, and (F) benzidine reagent.
In all cases, addition of catalase in a concentration of 0.1 mg/ml to the benzidine
reagent completely inhibited peroxidase activity within the electropherograms (Fig.
9). In striking contrast, catalase did not inhibit the utilization of tyrosine and/or
dopa by the multiple forms of tyrosinase from hair bulbs and melanoma (Fig. 9).
The intensity of melanin deposition at all tyrosinase positions within electrophero-
grams was unaffected by the addition of catalase to the incubation medium.
The radioassay method demonstrated tyrosine hydroxylation by melanoma T1
eluted from electropherogram "T1-fragments" which were dissected so as to ex-
clude contamination by peroxidase. T1 catalyzed the formation of 3HOH from 3,
5-3H-L-tyrosine as a byproduct in the conversion of tyrosine into dopa. T1 from
melanoma supernatant fractions trypsinized prior to electrophoresis showed a 2-
to 4-fold greater tyrosine hydroxylating capacity than that from nontrypsinized
supernatants. Addition of catalase (0.1 mg/ml of reaction mixture) did not prevent
the conversion of tyrosine into dopa (Table 1).
DISCUSSION
This study clearly indicates that murine tyrosinase derived from pigmented hair
bulbs and Harding-Passey melanoma is capable of catalyzing both the oxidation
of tyrosine to dopa and of dopa to higher melanogenic intermediates. In this re-
spect, it joins numerous other papers which have supported this interpretation for
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FIG. 6. Activity patterns of tyrosinase from Harding-Passey melanoma. Electropherograms
of untreated supernatant fractions incubated in (A) 0.07 mM dopa, and (B) 0.07 mM
dopa and 0.83 mM L-tyrosine; electropherograms of trypsin-treated supernatant fractions
incubated in (C) 0.07 mM dopa, and (D) 0.07 mM dopa and 0.83 mM L-tyrosine.
FIO. 7. Activity patLerns o1 tyrosinase in eiectropnerograms of trypsin-treated supernatant
fractions of C57BL hair bulb extracts: gels incubated in (A) 0.2 mM dopa, (B) 0.2 mM
dopa and 0.2 mM L-tyrosine, (C) 0.2 mM dopa and 0.4 mM L-tyrosine, (D) 0.2 mM
dopa and 2 mM L-tyrosine, (E) 0.2 mM dopa and 4 mM L-tyrosine, and (F) 0.2 mM
dopa and 8 mM L-tyrosine.
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FIG. 8. Activity patterns of tyrosinase and peroxidase from hair bulb extracts of yellow
mice. Electropherograms of untreated supernatant fractions incubated in (A) dopa, and
(C) benzidine reagent; electropherograms of trypsin-treated supernatant fractions incubated
in (B) dopa, and (D) benzidine reagent.
the role -of mammalian tyrosinase in the initial steps of the biosynthetic pathway
leading to melanin (1-9). It does not support the view that peroxidase acting either
alone or coupled with a dopa oxidase accounts for the enzymatic activities currently
attributed to mammalian tyrosinase (10, 11). Although the present study does
not rule out the possibility that peroxidase and tyrosinase (dopa oxidase) activities
are in some way coupled or synergistic in vivo, it does demonstrate that peroxidase
activity is not required to support the action of a mammalian tyrosinase defined
by its ability to convert tyrosine and dopa to melanin in vitro. Three lines of evi-
dence support this conclusion. First, all multiple forms of tyrosinase deposit tyro-
sine- and dopa-melanin when polyacrylamide gel electropherograms bearing these
enzymes are incubated in the presence of catalase in concentrations adequate to
block peroxidase activity. Second, tyrosine- and dopa-melanin are deposited at the
T, position in polyacrylamide gels in the absence of comigratory peroxidase. Third,
melanoma T, carefully isolated from polyacrylamide gels so as to exclude the
peroxidase comigratory with T, carries out the hydroxylation of tyrosine to dopa
in the presence and absence of catalase.
An appropriate molar ratio of tyrosine to dopa appears to be critical for demon-
strating the utilization of tyrosine by hair bulb tyrosinase within polyacrylamide
gels. This is most likely the result of substrate inhibition of the type reported by
Pomerantz (9). Since melanoma tyrosinase converts tyrosine to melanin at tyro-
sine/dopa molar ratios inhibitory to hair bulb tyrosinase, there is probably less
tyrosinase in the hair bulb extracts and hence a greater opportunity for substrate
inhibition to occur. This interpretation is consistent with the relatively fewer mela-
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FIG. 9. Influence of catalase on activity patterns of tyrosinase and peroxidase from trypsin-
treated supernatant fractions of C57BL hair bulb extracts: gels incubated in (A) 0.2 mM
dopa and catalase (0.1 mg/ml), (B) 0.2 mM tyrosine, 0.2 mM dopa and catalase (0.1
mg/mi), (C) benzidine reagent, and (D) benzidine reagent and catalase (0.1 mg/ml).
nin-forming cells in hair bulb preparations compared to those of melanomas and
the significant differences in the ease with which the two tyrosinase sources are
homogenized.
Based on evidence available to date, the enhanced T1 activity observed after
trypsinization of hair bulbs and melanoma supernatant fractions might result from
TABLE 1
TYROSINE HYDROXYLATING ACTIVITY OF ISOLATED T1 FROM HARDING-PASSEY MELANOMA
AS DETERMINED BY THE METHOD OF POMERANTZ (9)
cpm (3HOH)4
Activity of T1 isolated from electropherograms of Experiment
untreated and trypsin-treated supernatant fractions lb 2c 3d
Without trypsin treatment 517 200
With trypsin treatment 923 809 1873
With trypsin treatment + catalase added to the radioassay
reaction mixture (.1 mg/ml) 1400
a Background subtracted in all experiments (background = counts from a control sample to which
no T1 was added).
b Dopa treatment of one gel used to detect T1 position in remaining gels (T1 isolated from unstained
gels).
c T1 isolated after short incubation of all the gels in dopa.
dT1 isolated as in b; incubation time 1.5 hr as compared to 1 hr in Expts. 1 and 2.
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1) the conversion of protyrosinase to tyrosinase by enzymatic removal of a poly-
peptide forming part of its primary structure, or 2) the removal of an inhibitor
(21, 22) forming part of an inhibitor-tyrosinase complex possibly involving co-
valent linkages, or 3) the release of tyrosinase bound to cytomembranes (23).
The latter explanation would seem unlikely based on the observation of significant
tyrosinase activation in trypsinized supernatant fractions obtained at 100,000 g.
At present it is not possible to distinguish between the first and second possibilities.
Indications of a "true" protyrosinase in vertebrates comes from research on the
frog in which McGuire and associates have advanced considerable evidence for
a proenzyme activated by an appropriate endopeptidase (16, 17). They have tenta-
tively identified the fragment detached from the apoenzyme by the endopeptidase.
This finding suggests at least for lower vertebrates the existence of an additional
site for posttranslational control of tyrosinase activity and hence of melanogenesis.
The results of the present study, in a tentative way, raise the same possibility for
mammalian melanogenesis. A variety of proteases and protease inhibitors have
been demonstrated in mammalian skin (24, 25). Possibly represented in this as-
semblage is a protease devoted to the activation of protyrosinase. Lee and Lee
(26) have proposed that the MSH-induced enhancement of melanogenesis within
frog skin may involve the hormone-induced release of a protease which in turn
activates protyrosinase. In view of the observed enhancement of mammalian
melanogenesis by MSH (22, 27), it is possible that a similar mechanism may be
involved. Lee, Lee, and Lu (22), however, proposed that MSH enhances mam-
malian tyrosinase activity by the removal of an inhibitor from tyrosinase molecules.
The observation that additional T1 is formed by trypsinization of supernatant
fractions lends further support to a view advanced earlier that T1 stands close to
the primary action of the c locus (13). More direct evidence for the existence
of mammalian protyrosinase is currently being sought.
SUMMARY
The multiple forms of tyrosinase isolated from pigmented hair bulbs and Hard-
ing-Passey melanoma of mice have been demonstrated to utilize tyrosine and dopa
in the synthesis of melanin within polyacrylamide gel electropherograms. Although
peroxidase activity can be demonstrated in electropherograms of extracts of these
tissues, there appears to be no requirement for peroxidase support of tyrosinase
in the utilization of tyrosine or dopa as a melanogenic substrate. Hair bulb and
melanoma tyrosinases utilize tyrosine and dopa in the presence of catalase sufficient
to block peroxidase activity within polyacrylamide gels. The sensitive Pomerantz
radioassay reveals that tyrosinase, isolated from electropherograms without asso-
ciated peroxidase, catalyzes the hydroxylation of tyrosine both in the presence and
absence of catalase. Although alternative theories are not excluded, the observed
enhancement of tyrosinase (T1) activity on treatment of hair bulb and melanoma
supernatant fractions with trypsin might indicate the existence of a mammalian
"protyrosinase" akin to that demonstrated in amphibians by other investigators.
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